Target intelligence / Profile preview

Latrophilin G protein-coupled receptor (Latrophilin (Lphn); for individual isoforms: Latrophilin-1 (Lphn1), Latrophilin-2 (Lphn2), Latrophilin-3 (Lphn3))

Target
Latrophilin (Lphn); for individual isoforms: Latrophilin-1 (Lphn1), Latrophilin-2 (Lphn2), Latrophilin-3 (Lphn3)
Molecular classification
G protein-coupled receptor, Adhesion G protein-coupled receptor, Receptor
01

Overview

Latrophilins are a subset of adhesion G protein–coupled receptors (adhesion-GPCRs), with three main isoforms: Latrophilin-1 (ADGRL1), Latrophilin-2 (ADGRL2), and Latrophilin-3 (ADGRL3)[4][5][8]. **Latrophilins** are membrane receptors characterized by a large N-terminal extracellular region (including lectin and olfactomedin domains) linked through a GAIN domain to a seven-transmembrane GPCR core[4][5][8]. They are best known as the brain receptors for α-latrotoxin (from black widow spider venom), which triggers massive exocytosis at synapses[4][7]. Functionally, latrophilins mediate both cell adhesion and classical GPCR signal transduction, including constitutive and ligand-induced increases in cAMP[1][3][6]. Latrophilin-2 and Latrophilin-3, in particular, are essential for synapse formation and proper connectivity in the hippocampus, acting postsynaptically in trans-synaptic complexes with proteins such as teneurins and FLRTs[1][3][6][9]. Emerging data suggest roles in heart development (Latrophilin-2), cell proliferation, and cancer stem cell function. While not presently targeted by pharmacological drugs, latrophilins are of increasing interest in neuroscience and regenerative medicine due to their specific and essential signaling roles[5][8].

Other names
Adhesion G protein-coupled receptor L1 (ADGRL1, Latrophilin-1)Adhesion G protein-coupled receptor L2 (ADGRL2, Latrophilin-2)Adhesion G protein-coupled receptor L3 (ADGRL3, Latrophilin-3)LPHN1, LPHN2, LPHN3Latrophilin receptor
02

Mechanism of action

Agonism by α-latrotoxin triggers exocytosis at neuron synapses (extreme depolarization); Synthetic *Stachel* peptides can activate the receptor via the conserved tethered agonist sequence in the GAIN domain

03

Biological functions

Signal transductionCell adhesionSynapse formationNeural developmentCell-cell communicationPotential regulation of energy and glucose balance
04

Disease associations

Neurodevelopmental disorderNeurodegenerative diseaseCardiovascular diseaseCancer
05

Safety considerations

No known major toxicity; however, activation by α-latrotoxin results in toxic massive neurotransmitter releasePotential concerns in neural or cardiac targeting due to widespread, multifaceted biological rolesLimited druggability compared to classical GPCRs due to complex biology
06

Interacting drugs

α-latrotoxin (black widow spider venom neurotoxin; not therapeutic but key chemical probe)

1 more in the full profile.

07

Biomarkers

Latrophilin-2 (Lphn2) is a marker for cardiomyocytes and heart developmentLphn2 overexpression has been reported as a possible cancer stem cell marker in glioblastoma stem-like cells

Beyond the preview

Go deeper on Latrophilin G protein-coupled receptor (Latrophilin (Lphn); for individual isoforms: Latrophilin-1 (Lphn1), Latrophilin-2 (Lphn2), Latrophilin-3 (Lphn3)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Latrophilin G protein-coupled receptor (Latrophilin (Lphn); for individual isoforms: Latrophilin-1 (Lphn1), Latrophilin-2 (Lphn2), Latrophilin-3 (Lphn3)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call